Cambridge Epigenetix has a vision to improve healthcare through routine measurement of the epigenome.
Location: United Kingdom, England, Cambridge
Employees: 51-200
Total raised: $144.5M
Founded date: 2012
Investors 5
| Date | Name | Website |
| - | Sequoia Ca... | sequoiacap... |
| - | Third Poin... | thirdpoint... |
| - | New Scienc... | newscience... |
| - | Ahren Inno... | ahreninnov... |
| - | GV | gv.com |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 02.11.2021 | Series D | $88M | - |
| 02.04.2018 | - | $30M | Ahren Inno... |
| 14.03.2016 | Series B | $21M | Illumina A... |
| 29.10.2014 | Series A | $5.5M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 03.11.2021 | Cambridge Epigenetix raises $88m Series D financing to advan... | Cambridge Epigenetix raises $88m Series D financing to advance DNA sequencing technology platform 0... | cambridgen... |
| 03.11.2021 | Cambridge Epigenetix raises $88m Series D financing to advan... | Cambridge Epigenetix (CEGX), a life sciences tools and technology company revolutionising genome seq... | cambridgen... |
| 02.11.2021 | Cambridge Epigenetix Raises $88 Million Series D Financing t... | Technology increases the amount and quality of data that can be efficiently and cost-effectively obt... | globenewsw... |
| 02.11.2021 | Cambridge Epigenetix Raises $88 Million Series D Financing t... | Technology increases the amount and quality of data that can be efficiently and cost-effectively obt... | marketscre... |
| 03.09.2019 | Tom Hulme from GV is joining us at Disrupt Berlin | Based in London, Tom Hulme is a general partner for GV, the VC firm formerly known as Google Venture... | techcrunch... |
| 02.04.2018 | Ahren Leads $30mn Funding Round in Cambridge Epigenetix | - | ahreninnov... |
| 30.03.2017 | SpyBiotech, which makes a ‘superglue’ for vaccines, raises £... | The startup bug has hit the world of biotechnology, and the latest victim is a business that is buil... | techcrunch... |
| 17.03.2016 | Google’s GV leads $21M Series B in bioscience firm Cambridge... | VC firm GV (née Google Ventures) has made another investment in Europe — its seventh — leading a $21... | techcrunch... |
| 14.03.2016 | Cambridge Epigenetix announces $21M Series B financing and a... | Cambridge Epigenetix (CEGX), a pioneer in the development of epigenetic sequencing technologies, tod... | cambridgen... |
| 14.03.2016 | Cambridge Epigenetix announces $21M Series B financing and a... | Cambridge Epigenetix announces $21M Series B financing and appoints Dr Geoff Smith as CEO 14-03-201... | cambridgen... |
Show more